Literature DB >> 20167379

Production of immune-modulatory nonclassical molecules HLA-G and HLA-E by tumor infiltrating ameboid microglia/macrophages in glioblastomas: a role in innate immunity?

Leos Kren1, Katarina Muckova, Eva Lzicarova, Marek Sova, Vaclav Vybihal, Tomas Svoboda, Pavel Fadrus, Martin Smrcka, Ondrej Slaby, Radek Lakomy, Petr Vanhara, Zdenka Krenova, Jaroslav Michalek.   

Abstract

The possible role of immune-modulatory nonclassical molecules HLA-G and HLA-E in an anti-tumoral response and development of glioblastoma is not well characterized. In this study, we evaluated an expression of HLA-G and HLA-E by activated tumor infiltrating microglia/macrophages. We found production of HLA-G and HLA-E by tumor infiltrating activated microglia/macrophages in a majority of glioblastomas. We speculate that the expression of these molecules by activated microglia/CNS macrophages plays a role in the anti-tumoral immunity in the development of glioblastoma. Mechanisms of microglia-glioblastoma cell interactions with respect to the expression of these molecules deserves further study. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167379     DOI: 10.1016/j.jneuroim.2010.01.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  22 in total

Review 1.  Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site.

Authors:  Elaheh Nasrollahzadeh; Sepideh Razi; Mahsa Keshavarz-Fathi; Massimiliano Mazzone; Nima Rezaei
Journal:  Cancer Immunol Immunother       Date:  2020-06-04       Impact factor: 6.968

Review 2.  Molecular alterations in glioblastoma: potential targets for immunotherapy.

Authors:  Azizul Haque; Naren L Banik; Swapan K Ray
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 3.  HLA-G regulators in cancer medicine: an outline of key requirements.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Tumour Biol       Date:  2011-07-27

4.  Glioma-derived T cell immunoglobulin- and mucin domain-containing molecule-4 (TIM4) contributes to tumor tolerance.

Authors:  Lunshan Xu; Hualiang Xiao; Minhui Xu; Chun Zhou; Liang Yi; Hong Liang
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

Review 5.  The perivascular niche microenvironment in brain tumor progression.

Authors:  Nikki Charles; Eric C Holland
Journal:  Cell Cycle       Date:  2010-08-01       Impact factor: 4.534

6.  Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.

Authors:  Isabela J Wastowski; Renata T Simões; Layale Yaghi; Eduardo A Donadi; João T Pancoto; Isabelle Poras; Emmanuèle Lechapt-Zalcman; Myriam Bernaudin; Samuel Valable; Carlos G Carlotti; Sébastien Flajollet; Stine S Jensen; Soldano Ferrone; Edgardo D Carosella; Bjarne W Kristensen; Philippe Moreau
Journal:  Am J Pathol       Date:  2012-12-04       Impact factor: 4.307

Review 7.  The Dynamics of Interactions Among Immune and Glioblastoma Cells.

Authors:  Katalin Eder; Bernadette Kalman
Journal:  Neuromolecular Med       Date:  2015-07-30       Impact factor: 3.843

Review 8.  Tumor-associated macrophages: from mechanisms to therapy.

Authors:  Roy Noy; Jeffrey W Pollard
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745

9.  Pan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment.

Authors:  Linbang Wang; Tao He; Jingkun Liu; Jiaojiao Tai; Bing Wang; Zhiyu Chen; Zhengxue Quan
Journal:  Exp Hematol Oncol       Date:  2021-05-10

10.  Increased HLA-E expression in white matter lesions in multiple sclerosis.

Authors:  Pascal F Durrenberger; Louise V Webb; Malcolm J W Sim; Richard S Nicholas; Daniel M Altmann; Rosemary J Boyton
Journal:  Immunology       Date:  2012-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.